Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the beta-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the beta-catenin pathway for self-renewal. METHODS: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, beta-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear beta-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on beta-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the beta-catenin pathway. RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear beta-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. CONCLUSIONS: Activation of beta-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both myelodysplastic syndrome (Pang et al., 2013) and acute and chronic myelogenous leukemias begin with nonlethal mutations in the HSC pool, often leading to successful expansion of mutant HSC clones at the expense of normal HSC, and which progress eventually to leukemia (Corces-Zimmerman et al., 2014; Jamieson et al., 2004; Jan et al., 2012)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Jamieson et al., 2004
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Self-citationConstitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationA minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Self-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Self-citation
Cited by
Items 501–600 of 1,000
The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders
Wagner, E. R., Zhu, G., Zhang, B., Luo, Q., Shi, Q., Huang, E., Gao, Y., Gao, J., Kim, S. H., Rastegar, F., et al. (2011) · Current Molecular Pharmacology · doi:10.2174/1874-470211104010014 · Cited by 79
“Mutations in -catenin and its associated transcription factors have been implicated in hair follicle and sebaceous gland tumors, as well as cancers of the hematopoietic system [113-115].”
CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
Chang, G., Zhang, H., Wang, J., Zhang, Y., Xu, H. Z., Wang, C., Zhang, H., Ma, L., Li, Q., & Pang, T. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-117 · Cited by 57
“expression of BCR-ABL is required for sustained proliferation of leukemic cells in mouse models of CML [4,5].”
BackgroundXiang, W., Cheong, J. K., Ang, S. H., Teo, B., Xu, P., Asari, K., Sun, W. T., Than, H., Bunte, R. M., Virshup, D. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5615 · Cited by 57
Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells
Relation, T., Dominici, M., & Horwitz, E. M. (2017) · Stem Cells · doi:10.1002/stem.2596 · Cited by 60
Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
Vessoni, A. T., Filippi‐Chiela, E. C., Lenz, G., & Batista, L. F. Z. (2019) · Oncogene · doi:10.1038/s41388-019-1128-4 · Cited by 60
“genitors can acquire self-renewal potential and the ability to propagate leukemia through increased β-catenin activation [54].”
BackgroundImpaired DNA Replication within Progenitor Cell Pools Promotes Leukemogenesis
Bilousova, G., Marusyk, A., Porter, C. C., Cardiff, R. D., & DeGregori, J. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030401 · Cited by 55
Wu, C. J., Biernacki, M. A., Kutok, J. L., Rogers, S. A., Chen, L., Yang, X., Soiffer, R. J., & Ritz, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0036 · Cited by 61
Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer
Michael, D. C. (2010) · Frontiers in bioscience · doi:10.2741/3693 · Cited by 59
“Indeed, Jamieson and colleagues (52) demonstrated that normal blood progenitor cells could give rise to leukemic stem cells in human chronic myelogenous leukemia (CML) through aberrant beta-catenin accumulation.”
BackgroundTargeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia
Słupianek, A., Dasgupta, Y., Ren, S., Gurdek, E., Donlin, M., Nieborowska-Skorska, M., Fleury, F., & Skórski, T. (2011) · Blood · doi:10.1182/blood-2010-09-307256 · Cited by 55
Osaki, M., Okada, F., & Ochiya, T. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.122 · Cited by 56
Reddiconto, G., Toto, C., Palamà, I. E., Leo, S. D., de Luca, E., Matteis, S. D., Dini, L., Gambacorti-Passerini, C. B., Renzo, N. D., Maffia, M., et al. (2012) · Blood · doi:10.1182/blood-2011-06-361261 · Cited by 60
Nygren, M. K., Døsen, G., Hystad, M. E., Stubberud, H., Funderud, S., & Rian, E. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06442.x · Cited by 54
“Wnt signalling has also been implicated in haematological malignancies (Jamieson et al, 2004; Lu et al, 2004; Muller-Tidow et al, 2004; Serinsoz et al, 2004), but to date, the role of canonical Wnt signalling via b-catenin versus non-canonical Wnt pathways has been inadequately investigated.”
BackgroundSomatic stem cells and the origin of cancer
Martinez-Climent, J. A., Andreu, E. J., & Prósper, F. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0035-7 · Cited by 61
Molecular biology of chronic myeloid leukemia
Maru, Y. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02346.x · Cited by 60
Hematopoietic Stem Cells Are Intrinsically Protected against MLL-ENL-Mediated Transformation
Ugale, A. S., Norddahl, G. L., Wahlestedt, M., Säwén, P., Jaako, P., Pronk, C. J., Soneji, S., Cammenga, J., & Bryder, D. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.036 · Cited by 56
“…syndromes, chronic myelogenous leukemia, and de novo AML have suggested a role for HSCs as a reservoir for accumulating mutations in the preliminary phases of disease (Hong et al., 2008; Jamieson et al., 2004; Jan et al., 2012; Klco et al., 2014; Nilsson et al., 2002; Shlush et al., 2014).”
Backgroundβ-Arrestin2 mediates the initiation and progression of myeloid leukemia
Fereshteh, M., Ito, T., Kovacs, J. J., Zhao, C., Kwon, H. Y., Tornini, V. A., Konuma, T., Chen, M., Lefkowitz, R. J., & Reya, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209815109 · Cited by 55
Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells
Zhang, B., Li, L., Ho, Y., Li, M., Marcucci, G., Tong, W., & Bhatia, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci79196 · Cited by 53
Lin, H., Rothe, K., Chen, M., Wu, A., Babaian, A., Yen, R., Zeng, J., Rüschmann, J., Petriv, O. I., O’Neill, K., et al. (2020) · Blood · doi:10.1182/blood.2019003636 · Cited by 55
Stemming Cancer: Functional Genomics of Cancer Stem Cells in Solid Tumors
Regenbrecht, C. R. A., Lehrach, H., & Adjaye, J. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9034-0 · Cited by 60
“The WNT signaling pathway has also been implicated in both stem cell self-renewal and cancer [59–61], and has been shown specifically to be active in the CSC population of human CML blast crisis patients [62].”
BackgroundThe kinetics of clonal dominance in myeloproliferative disorders
Catlin, S. N., Guttorp, P. M., & Abkowitz, J. L. (2005) · Blood · doi:10.1182/blood-2005-03-1240 · Cited by 61
Perrotti, D., & Neviani, P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603317 · Cited by 53
“…and activity of the BCR/ABL oncoprotein is frequently observed during CML disease progression and in blast crisis CML (Elmaagacli et al, 2000; Jamieson et al, 2004; Barnes et al, 2005b), and sustained BCR/ABL expression in myeloid progenitor cell lines induces phenotypic changes (i.e.…”
BackgroundAdhikary, A., Mukherjee, A., Banerjee, R., & Nagotu, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c06547 · Cited by 62
Biernacki, M. A., Marina, O., Zhang, W., Liu, F., Bruns, I., Cai, A., Neuberg, D. S., Canning, C. M., Alyea, E. P., Soiffer, R. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2303 · Cited by 52
“Tumor-initiating cells have been identified for several hematologic malignancies, including CML (20).”
BackgroundSignal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects
Campbell, C., Risueno, R. M., Salati, S., Guezguez, B., & Bhatia, M. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328303b9df · Cited by 52
Oncogenic signaling: new insights and controversies from chronic myeloid leukemia
Etten, R. A. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062335 · Cited by 56
“, the leukemiainitiating or leukemic “stem” cells) differ between the MPD and blast phases of the disease, which is reminiscent of human CML (15).”
BackgroundRac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo
Sengupta, A., Arnett, J., Dunn, S., Williams, D. A., & Cancelas, J. A. (2010) · Blood · doi:10.1182/blood-2009-10-247437 · Cited by 52
Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells.
Saki, N., Abroun, S., Hagh, M. F., & Asgharei, F. (2011) · PubMed Central · Cited by 51
Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
Hamad, A., Sahli, Z. T., Sabban, M. E., Mouteirik, M., & Nasr, R. (2013) · Stem Cells International · doi:10.1155/2013/724360 · Cited by 58
Roos, J., Oancea, C., Heinßmann, M., Khan, D., Held, H., Kahnt, A. S., Capelo, R., la Buscató, E., Proschak, E., Puccetti, E., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3012 · Cited by 55
“This is supported by the finding that the activation of Wnt signaling in LSC is not related to upregulation of COX, but is related to the presence of aberrant chimeric transcription factors resulting from chromosomal translocations such as t(15;17)-PML/RARa or t(8;21) AML-1/ETO fusion proteins (10, 12).”
BackgroundCBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells
Zhao, Y., Masiello, D., McMillian, M., Nguyen, C., Wu, Y., Melendez, E., Smbatyan, G., Kida, A., He, Y. J., Teo, J.-L., et al. (2015) · Oncogene · doi:10.1038/onc.2015.438 · Cited by 54
Influence of Bone Marrow Microenvironment on Leukemic Stem Cells
Agarwal, P., & Bhatia, R. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.007 · Cited by 57
Bcr-Abl induces autocrine IGF-1 signaling
Lakshmikuttyamma, A., Pastural, É., Takahashi, N., Sawada, K., Sheridan, D. P., DeCoteau, J. F., & Geyer, C. R. (2008) · Oncogene · doi:10.1038/onc.2008.8 · Cited by 55
“Recently, it has been proposed that a CML BC stem cell with self-renewal capacity exists that has undergone partial differentiation toward a granulocytemacrophage progenitor (Jamieson et al., 2004).”
BackgroundSu, W., Meng, F., Huang, L., Zheng, M., Liu, W., & Hanying, S. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.01.003 · Cited by 52
“As another highly conserved pathway during embryogenesis, Wnt/b-catenin signaling, plays an essential role in survival and expansion of CML stem/progenitor cells [19–21], we also investigate the relationship of Shh signaling and b-catenin signaling in CML progenitor cells.”
BackgroundG-CSF receptor mutations in patients with congenital neutropenia
Germeshausen, M., Skokowa, J., Ballmaier, M., Zeidler, C., & Welte, K. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328303b9f6 · Cited by 51
WNT Signaling in Hematological Malignancies
Frenquelli, M., & Tonon, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.615190 · Cited by 55
“In chronic myelogenous leukaemia (CML), increased levels of nuclear b- catenin were detected, thus enhancing the selfrenewal capacity of CML cells both in vitro (35) and in animal models (36).”
BackgroundDo we need more drugs for chronic myeloid leukemia?
Holyoake, T. L., & Helgason, G. V. (2014) · Immunological Reviews · doi:10.1111/imr.12234 · Cited by 53
Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
Stefanski, C. D., & Prosperi, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217844 · Cited by 59
“Uncontrolled Wnt signaling in granulocyte-macrophage progenitor cells enhanced the self-renewal and leukemic potential [20].”
BackgroundLeukemic Stem Cells: Where do They Come From?
Passegue, E. A., & Weisman, I. L. (2005) · Stem Cell Reviews and Reports · doi:10.1385/scr:1:3:181 · Cited by 61
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms
Cruceru, M. L., Neagu, M. T., Demoulin, J., & Constantinescu, S. N. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12122 · Cited by 56
“Colony Forming Unit Granulocyte Macrophage CFUGM) that acquired self-renewal [35].”
Mimeault, M., & Batra, S. K. (2010) · PubMed · doi:10.14670/hh-25.1057 · Cited by 56
“…esophageal, gastrointestinal, colon, bladder, pancreatic, prostate, mammary and ovarian cancers (Al-Hajj and Clarke, 2004; Hope et al., 2004; Jamieson et al., 2004; Matsui et al., 2004; Singh et al., 2004; Fang et al., 2005; Kim et al., 2005; Ponti et al., 2005; Maitland et al., 2006;…”
BackgroundInfluentialSu, Y., Li, S.-C., Wu, Y.-C., Wang, L., Chao, K. S. C., & Liao, H. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/547430 · Cited by 48
RetractedThe stem cell niche in health and malignancy
Burness, M. L., & Sipkins, D. A. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.006 · Cited by 52
“[25] Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al.”
BackgroundGenomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression
Brazma, D., Grace, C. D., Howard‐Reeves, J., Melo, J. V., Holyoke, T., Apperley, J. F., & Nacheva, E. P. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20487 · Cited by 48
“This observation lends support to the current model of CML (Goldman and Melo, 2003; Jamieson et al., 2004) based on the assumption that increased and/or continuous BCR/ ABL1 expression promotes consecutive molecular and chromosomal changes, which leads to expansion of differentiation-arrested and…”
ResultCross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance
Scheller, M., Schönheit, J., Zimmermann, K., Leser, U., Rosenbauer, F., & Leutz, A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130706 · Cited by 48
“Activation of -catenin determines the extent of gene regulation in leukemic GMPs from chronic to BP transition Similar to the results shown here, expansion of progenitors and reduction of HSC was found in the BM from patients with blast-crisis CML (Jamieson et al., 2004).”
BackgroundMethodResultInfluentialCell Homogeneity Indispensable for Regenerative Medicine by Cultured Human Corneal Endothelial Cells
Hamuro, J., Toda, M., Asada, K., Hiraga, A., Schlötzer-Schrehardt, U. M., Montoya, M. M., Sotozono, C., Ueno, M., & Kinoshita, S. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19770 · Cited by 48
Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells
Ji, Q., Ding, Y., Sun, Y. M., Zhang, Y., Gao, H., Song, H., Yang, M., Liu, X., Zhang, Z.-X., Li, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11342 · Cited by 49
“The presence of leukemic stem cells (LSCs) has been confirmed in several human hematological malignancies, and is considered as a key factor that contributes to the initiation, maintenance, relapse, and drug-resistance of leukemia [1, 2].”
BackgroundWnt Signaling in Normal and Malignant Stem Cells
Bhavanasi, D., & Klein, P. S. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0068-y · Cited by 51
Lai, D., Chen, M., Su, J., Liu, X., Rothe, K., Hu, K., Forrest, D. L., Eaves, C. J., Morin, G. B., & Jiang, X. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8735 · Cited by 47
Sakoda, T., Kikushige, Y., Miyamoto, T., Irifune, H., Harada, T., Hatakeyama, K., Kunisaki, Y., Kato, K., & Akashi, K. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008405 · Cited by 48
Cancer Stem Cells Protect Non‐Stem Cells From Anoikis: Bystander Effects
Kim, S., Hong, S., Basse, P. H., Wu, C., Bartlett, D. L., Kwon, Y. T., & Lee, Y. J. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25527 · Cited by 51
“…colleagues have suggested that not only long-term hematopoietic stem cells, but also committed short-lived myeloid progenitors can be transformed and give rise to tumors with comparable latencies, phenotypes, and gene expression profiles [Cozzio et al., 2003; Jamieson et al., 2004; Weissman, 2005].”
BackgroundResultLi, F., He, B., Ma, X., Yu, S., Bhave, R. R., Lentz, S. R., Tan, K., Guzmán, M. L., Zhao, C., & Xue, H. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.08.001 · Cited by 48
“…is involved in many aspects of leukemogenesis, including development of LSCs in pre-clinical models of CML and acute myeloid leukemia (AML) (Jamieson et al., 2004; Wang et al., 2010; Zhao et al., 2007). b-catenin is also necessary for maintaining CML LSCs (Heidel et al., 2012) and is a…”
BackgroundInfluentialRole of WNT signaling in normal and malignant hematopoiesis.
Khan, N. I., & Bendall, L. J. (2006) · PubMed · doi:10.14670/hh-21.761 · Cited by 51
The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells
Che, S., Zhang, X.-Z., Liu, X., Chen, X., & Hou, L. (2010) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01138.x · Cited by 47
Yong, A. S. M., Keyvanfar, K., Eniafe, R. B., Savani, B. N., Rezvani, K., Sloand, E. M., Goldman, J. M., & Barrett, A. J. (2008) · Leukemia · doi:10.1038/leu.2008.161 · Cited by 47
“CD34pCD38-Lin−CD90p hematopoietic stem cells (HSC)”
Sicinska, E., Lee, Y.-M., Gits, J., Shigematsu, H., Yu, Q., Rebel, V. I., Geng, Y., Marshall, C. J., Akashi, K., Dorfman, D. M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00800-06 · Cited by 45
“Given that abnormal proliferation of hematopoietic cells is an underlying cause of several human diseases, such as leukemias and aplastic syndromes (16, 24, 42), it is important to elucidate the mechanisms that govern normal proliferation of these lineages.”
BackgroundHmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice
Lam, K., Muselman, A., Du, R., Harada, Y., Scholl, A. G., Yan, M., Matsuura, S., Weng, S., Harada, H., & Zhang, D.-E. (2014) · Blood · doi:10.1182/blood-2014-02-554543 · Cited by 46
“RUNX1(41-214) (RUNX1SF) is primarily a dominant-negative competitor of endogenous RUNX proteins.”
BackgroundThe CML stem cell: Evolution of the progenitor
Stuart, S. A., Minami, Y., & Wang, J. Y. J. (2009) · Cell Cycle · doi:10.4161/cc.8.9.8209 · Cited by 49
Porro, A., Iraci, N., Soverini, S., Diolaiti, D., Gherardi, S., Terragna, C., Durante, S., Valli, E., Kalebic, T., Bernardoni, R., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0510 · Cited by 46
“Furthermore, in CML, CD34þ hematopoietic progenitors carry the t(9;22) (q34;q11) reciprocal chromosomal translocation (chromosome Ph), which gives rise to the BCR-ABL proto-oncogene and its constitutively active protein tyrosine kinase product p210/BCR-ABL (3).”
BackgroundStem cell biology and the cellular pathways of carcinogenesis
Guðjónsson, Þ., & Magnússon, M. K. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm_371.x · Cited by 60
“Recent results from Irving Weissman’s laboratory indicate that during the transformation of CML to its more aggressive blastic phase, committed CML cells exhibiting the granulocyte monocyte progenitor (GMP) phenotype might acquire stem cell properties (33).”
ResultCell Fusion, Drug Resistance and Recurrence CSCs
Nagler, C., Zänker, K. S., & Dittmar, T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0782-5_9 · Cited by 45
“Within the past 15 years, CSCs have been identified in a variety of cancers including acute myeloma leukemia (AML) [20], chronic myeloid leukemia (CML) [21], brain [22], melanoma [23], colon [24], colorectal [25], pancreatic [26], prostate [27], and lung cancer [28].”
Backgroundc-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells
Waldron, T. J., Dominici, M. D., Soliera, A. R., Audia, A., Iacobucci, I., Lonetti, A., Martinelli, G., Zhang, Y., Martinez, R., Hyslop, T., et al. (2011) · Leukemia · doi:10.1038/leu.2011.264 · Cited by 46
“…transcription factors; besides members of the STAT family, p210 BCR/ABL enhances the expression of c-Myc (12) and the activity of the B-catenin/LEF-1 and the Hedgehog pathways, both of which may regulate the self-renewal of normal and BCR/ABL-transformed mouse and human progenitor subsets (13–15).”
Eiring, A. M., Neviani, P., Santhanam, R., Oaks, J. J., Chang, J. S., Notari, M., Willis, W., Gambacorti-Passerini, C., Volinia, S., Marcucci, G., et al. (2008) · Blood · doi:10.1182/blood-2007-05-090472 · Cited by 45
MUC1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells
Kawano, T., Ito, M., Raina, D. B., Wu, Z., Rosenblatt, J. M., Avigan, D., Stone, R. M., & Kufe, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2756 · Cited by 45
“Suppression of h-catenin with axin decreased selfrenewal capacity and leukemic potential of these cells, indicating that dysregulation of h-catenin contributes to development of the blast phase (9).”
BackgroundMethodInfluentialHuang, W., Zhou, W. J., Saberwal, G. S., Konieczna, I., Horvath, E., Katsoulidis, E., Platanias, L. C., & Eklund, E. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-09 · Cited by 50
“representing Gas2, DN-Gas2, and Gas2(1-279) using previously described tech-”
MethodInfluentialA STAT5B–CD9 axis determines self-renewal in hematopoietic and leukemic stem cells
Kollmann, S., Grausenburger, R., Klampfl, T., Prchal‐Murphy, M., Bastl, K., Pisa, H., Knab, V. M., Brandstoetter, T., Doma, E., Sperr, W. R., et al. (2021) · Blood · doi:10.1182/blood.2021010980 · Cited by 49
Zhou, H., Ge, Y., Sun, L., Ma, W., Wu, J., Zhang, X., Hu, X., Eaves, C. J., Wu, D., & Zhao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086195 · Cited by 45
“The granulocytmarcrophage progenitor cells in blast crisis or IM resistant CML had elevated nuclear localized beta-catenin, which was proved to be critical for the self-renewal of CML primitive cells in vitro [27].”
BackgroundAdaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells
Baykal, S., Açıkgöz, E., Yavuz, A. S., Geyik, Ö. G., Ateş, H., Sezerman, O. U., Özsan, G. H., & Yüce, Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229104 · Cited by 45
“K562-IR cells are negative for CD34 but positive for another stem cell marker CD44; and as CML LSCs, they are BCR-Abl independent.”
BackgroundInfluentialEiring, A. M., Khorashad, J. S., Anderson, D. J., Yu, F., Redwine, H. M., Mason, C. C., Reynolds, K. R., Clair, P. M., Gantz, K. C., Zhang, T. Y., et al. (2015) · Leukemia · doi:10.1038/leu.2015.196 · Cited by 46
Gut stem cells in tissue renewal and disease: methods, markers, and myths
Rizk, P., & Barker, N. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1176 · Cited by 57
Bone marrow neoplastic niche in leukemia
Azizidoost, S., Babashah, S., Rahim, F., Shahjahani, M., & Saki, N. (2013) · Hematology · doi:10.1179/1607845413y.0000000111 · Cited by 48
Cancer Stem Cells: A New Theory Regarding a Timeless Disease
Sarkar, B., Dosch, J. S., & Simeone, D. M. (2009) · Chemical Reviews · doi:10.1021/cr9000397 · Cited by 47
Carter, B. Z., Mak, P. Y., Mak, D. H. F., Ruvolo, V. R., Schober, W. D., McQueen, T. J., Cortes, J. E., Kantarjian, H. M., Champlin, R. E., Konopleva, M. Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5890 · Cited by 45
“Furthermore, in addition to the stem/progenitor cells derived from hematopoietic stem cells as described in chronic phase CML, the committed granulocyte-macrophage progenitors in BC CML gain an abnormal self-renewal capacity [10] that is responsible for”
BackgroundTargeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy
McCubrey, J. A., Steelman, L. S., Abrams, S. L., Misaghian, N., Chappell, W. H., Mijatović, S., Montalto, G., Cervello, M., Laidler, P. M., Bonati, A., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799859701 · Cited by 44
“The WNT pathway is frequently dysregulated in AML [27].”
BackgroundInfluentialProstate cancer stem cell biology.
Yu, C., Yao, Z., Jiang, Y., & Keller, E. T. (2012) · PubMed · Cited by 53
Inflammation-driven deaminase deregulation fuels human pre-leukemia stem cell evolution
Jiang, Q., Isquith, J. M., Ladel, L., Mark, A., Holm, F., Mason, C. N., He, Y., Mondala, P. K., Oliver, I., Pham, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108670 · Cited by 49
Xu, J., Suzuki, M., Niwa, Y., Hiraga, J., Nagasaka, T., Ito, M., Nakamura, S., Tomita, A., Abe, A., Kiyoi, H., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06914.x · Cited by 44
“Up-regulation of the beta-catenin pathway has been suggested in chronic myeloid leukaemia (CML)-derived granulocyte-macrophage progenitor cells (GMPs) and multiple myeloma (MM) cells (Derksen et al, 2004; Jamieson et al, 2004).”
BackgroundStem cells and cancer: a deadly mix
Alison, M. R., Murphy, G., & Leedham, S. J. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0510-7 · Cited by 48
“In patients with CML in blast crisis, GMPs can become self-renewing CSCs, a change associated with Wnt pathway activation (Jamieson et al. 2004).”
BackgroundTargeting PP2A for cancer therapeutic modulation
Ronk, H., Rosenblum, J. S., Kung, T., & Zhuang, Z. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0330 · Cited by 50
Etet, P. F. S., Vecchio, L., & Kamdje, A. H. N. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.05.015 · Cited by 46
Do we have to kill the last CML cell?
Ross, D. M., Hughes, T. P., & Melo, J. V. (2010) · Leukemia · doi:10.1038/leu.2010.197 · Cited by 45
Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia
Hu, Z., Pan, X., Wu, F., Ma, L., Liu, D., Liu, Y., Feng, T., Meng, F., Liu, X., Jiang, Q., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006257 · Cited by 46
“In CML, BCR-ABL triggers tyrosine phosphorylation and hence stabilization and activation of bcatenin [39], which enhances the self-renewal and leukemic potential of CML stem/progenitors cells [69,70].”
BackgroundMarega, M., Piazza, R., Pirola, A., Redaelli, S., Mogavero, A., Iacobucci, I., Meneghetti, I., Parma, M., Pogliani, E. M., & Gambacorti-Passerini, C. B. (2010) · Leukemia · doi:10.1038/leu.2010.101 · Cited by 43
Ma, W., Gutiérrez, A., Goff, D. J., Geron, I., Sadarangani, A., Jamieson, C., Court, A. C., Shih, A. Y., Jiang, Q., Wu, C. C. N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039725 · Cited by 44
Pehlivan, M., Sercan, Z., & Sercan, H. O. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.013 · Cited by 43
Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives
Jinesh, G. G., Willis, D. L., & Kamat, A. M. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x08666131113123051 · Cited by 45
“This type of acquired CSC expansion is well documented in the case of acute myeloid leukemia, where transition from chronic myeloid leukemia to acute myeloid leukemia referred to as “blast crisis” is mediated by expansion of leukemic stem cells [137, 138].”
BackgroundEmerging role of microRNAs in cancer stem cells: Implications in cancer therapy
Garg, M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i8.1078 · Cited by 43
hsa-mir183/EGR1–mediated regulation of E2F1 is required for CML stem/progenitor cell survival
Pellicano, F., Park, L., Hopcroft, L. E. M., Shah, M., Jackson, L., Scott, M. T., Clarke, C. J., Sinclair, A., Abraham, S. A., Hair, A., et al. (2018) · Blood · doi:10.1182/blood-2017-05-783845 · Cited by 47
“As previously reported, CML SPC expressed high levels of BCR-ABL1 (Figure 1Aii) when compared to more mature cells prior to treatment.(40,48,49) Despite this, CML SPC showed no significant difference in the percentage of quiescent cells (Figure 1Bi-ii, replicates shown in Figure S1A).”
Chronic Myeloid Leukemia Blast Crisis Arises from Progenitors
Michor, F. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0638 · Cited by 43
“However, the following new evidence suggests that blasts might be produced from leukemic progenitors instead [ 23 ]: progression to blast crisis is associated with expansion of leukemic progenitors rather than leukemic stem cells; BCR-ABL expression levels increase in leukemic progenitors but are constant in leukemic…”
BackgroundAbkowitz, J. L., & Chen, J. (2007) · Blood · doi:10.1182/blood-2006-08-044503 · Cited by 42
“However, if imatinib is stopped, the myeloproliferative hematopoiesis quickly recurs, demonstrating that aberrant HSC persist and that the preferential expansion of BCR-ABL-positive cells distal to HSC, and not HSC expansion, is responsible for the neoplastic phenotype (22,23).”
BackgroundFrolova, O., Benito, J., Brooks, C. L., Wang, R., Korchin, B., Rowinsky, E. K., Cortes, J. E., Kantarjian, H. M., Andreeff, M., Frankel, A. E., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12978 · Cited by 41
“Moreover, mutations that arise in the kinase domain of ABL1, such as the substitution of threonine at position 315 with isoleucine (T315I), limit the effectiveness of imatinib and other second-generation TKIs and often lead to resistance and disease relapse (Jamieson et al, 2004).”
BackgroundReversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal
Holm, F., Hellqvist, E., Mason, C. N., Ali, S. A., Santos, N. P. D., Barrett, C. L., Chun, H.-J. E., Minden, M. D., Moore, R. A., Marra, M. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506943112 · Cited by 43
“Previously, we showed that progression from chronic phase (CP) to blast crisis (BC) chronic myeloid leukemia (CML) involved malignant reprogramming of BC progenitors into LSCs as a result of β-catenin activation (15).”
BackgroundWang, H., Jia, X.-H., Chen, J.-R., Yi, Y., Wang, J., Li, Y., & Xie, S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3738 · Cited by 44
Aval, S. F., Lotfi, H., Sheervalilou, R., & Zarghami, N. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.020 · Cited by 46
Stabilization of NF-κB-Inducing Kinase Suppresses MLL-AF9-Induced Acute Myeloid Leukemia
Xiu, Y., Dong, Q.-Z., Li, Q.-C., Li, F.-Y., Borcherding, N., Zhang, W.-Z., Boyce, B., Xue, H.-H., & Zhao, C. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.055 · Cited by 33
“This is not unprecedented: b-catenin has been shown to be critical for chronicmyeloid leukemia (CML) transformation and MLL-AF9-induced AML, although no mutations have been reported thus far (Jamieson et al., 2004; Wang et al., 2010).”
García, P., Clarke, M. L., Vegiopoulos, A., Berlanga, O., Camelo, A., Lorvellec, M., & Frampton, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.97 · Cited by 46
Correction: Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith‐Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/annotation/2aa6a20a-e63c-49b6-aeea-aae62435617f · Cited by 42
Twist-1, A Novel Regulator of Hematopoietic Stem Cell Self-Renewal and Myeloid Lineage Development
Dong, C.-Y., Liu, X., Wang, N., Wang, L., Yang, B., Ren, Q., Liang, H., & Ma, X. (2014) · Stem Cells · doi:10.1002/stem.1803 · Cited by 44
Wnt Signaling: Role in Regulation of Haematopoiesis
Undi, R. B., Gutti, U., Sahu, I., Sarvothaman, S., Pasupuleti, S. R., Kandi, R., & Gutti, R. K. (2015) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-015-0585-3 · Cited by 52
Self-renewal related signaling in myeloid leukemia stem cells
Heidel, F. H., Mar, B. G., & Armstrong, S. A. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0901-0 · Cited by 51
“In human disease, Ctnnb1 activation via the canonical Wnt pathway has been shown to occur in CML-blast crisis LSCs, which phenotypically resemble granulocyte macrophage progenitors (GMP) [ 41 ].”
BackgroundChronic Myeloid Leukemia Stem Cell Biology
Crews, L. A., & Jamieson, C. H. M. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0121-6 · Cited by 49
“CML represents an important paradigm for understanding the molecular evolution of cancer because it was the first cancer shown to be initiated at the hematopoietic stem cell level by BCRABL; the first cancer found to undergo blastic transformation following malignant reprogramming of committed progenitors [5, 6]; and…”
Background
Metadata
- Authors
- Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., Sawyers, C. L., & Weissman, I. L.
- Affiliations
- Stanford Medicine (US)
- University of Toronto (CA)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-12
- Volume
- 351
- Issue
- 7
- Pages
- 657-667
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012962381
- Cited by
- 1,485
- References
- 58
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 36 · 2022: 27 · 2021: 33 · 2020: 40 · 2019: 37 · 2018: 40 · 2017: 53 · 2016: 80 · 2015: 74 · 2014: 81 · 2013: 95 · 2012: 114
- FWCI
- 55.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL04409, K23HL004409)
- National Cancer Institute (2PO1CA49605, CA 86017, CA 55209, R01CA086017, P01CA049605)
- National Institute of Allergy and Infectious Diseases (5 T32 AI07290, T32AI007290)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- chronic myeloid leukemia, blast crisis, leukemia stem cells, CFU-GM, β-catenin signaling, BCR-ABL, self-renewal, Axin, imatinib resistance, hematopoietic stem cells, myeloid progenitor cells
- MeSH terms
- Imatinib Mesylate, Adult, Aged, Antineoplastic Agents, Benzamides, Blast Crisis, Colony-Forming Units Assay, Cytoskeletal Proteins, DNA-Binding Proteins, Female, Granulocytes, Hematopoietic Stem Cells, Humans, Macrophages, Male, Middle Aged, Piperazines, Pyrimidines, RNA, Neoplasm, Transcription Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Trans-Activators, Fusion Proteins, bcr-abl, Microscopy, Confocal, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.